Heritage diets have important health benefits and policy implications, review finds

As No­vo Nordisk hauls in huge sales from its pop­u­lar GLP-1 prod­ucts, the com­pa­ny is think­ing about a fu­ture be­yond obe­si­ty and di­a­betes. Dur­ing a

How do you com­pete against a drug that costs mere cents? On Tues­day, Ver­tex suc­ceed­ed where many drug­mak­ers have tried and failed — it pro­duced